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BACKGROUND: Carcinoma in situ (CIS) of the testis is considered to be a precancerous germinal cell lesion, but the precise cellular and
molecular mechanisms underlying transformation of CIS into invasive pluripotent cancer cells remain to be elucidated. Moreover, a
satisfactory animal model for the experimental study of germinal tumours has not been developed to date.
METHODS: We have developed a tumour model that involves the microinjection of green fluorescent protein-labelled embryonic stem
(ES) cells (which are functionally equivalent to CIS cells) into syngenic mouse seminiferous tubules, a unique cell microenvironment in
which germinal cells mature and CIS arise. To characterise the vascularisation of teratocarcinomas, which arise after cell transplant, we
used immunohistochemistry, together with a qualitative and quantitative analysis of scanning electron microscopy images of corrosion
casting samples.
RESULTS: Embryonic stem cells transplanted into seminiferous tubules did not differentiate into germinal cells, but rather they behaved
as invasive embryonal carcinoma (EC) stem cells. The vascular pattern of the experimental teratocarcinomas showed a highly
disorganised architecture, and some of the neoplastic capillaries were derived, at least in part, from the original transplanted ES cells.
CONCLUSION: The transplantation of pluripotent ES cells into seminiferous tubules efficiently recapitulates the early stages of
development of teratocarcinomas. Consequently, this method constitutes a novel in vivo model to study the mechanisms of invasion
and progression of experimental germinal tumours.
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Tissue-specific stem cell origin of many tumours is a widely
accepted theory (Are ´chaga, 1993; Shipitsin and Polyak, 2008).
Carcinoma in situ (CIS) of the testis is also recognised today as a
precursor lesion for embryonal carcinoma (EC) and other
germinal tumours (Skakkebaek, 1972). Moreover, EC cells, the
cancer stem cell of testis teratocarcinomas, have the peculiarity of
retaining the epiblast pluripotency of the original embryo during
tumour invasiveness and differentiation (Kleinsmith and Pierce,
1964; Pierce, 1967; Are ´chaga, 1993; Dı ´ez-Torre et al, 2004). Indeed,
some embryo microenvironments have an extraordinary capacity
to normalise their fate and differentiation (Brinster, 1974; Pierce
et al, 1986; Are ´chaga, 1998). These characteristics confer to EC
cells the ability to give rise to neoplastic tissue components derived
from the three germinal layers (teratoma). Interestingly enough,
recent publications have also reported the high similarities
between CIS cells and embryonic stem (ES) cells (Almstrup et al,
2006), and the easy transformation of ES to EC cells after
prolonged adaptation to culture conditions (Andrews et al,
2005). Finally, it is important to keep in mind that cultured
spermatogonial stem cells or modified ES cells, can be transplanted
into the seminiferous tubules to restore fertility, representing an
exciting possibility in the field of regenerative medicine (Ogawa
et al, 1997; Brinster, 2007).
The present article is focused on examining the characteristics
of the blood supply of a new tumour model based on the
transplantation of ES cells into the mouse seminiferous tubules. In
this regard, it is important to point out that the recruitment of new
blood vessels, which carry oxygen, nutrients and other metabolites,
is essential for the growth of cellular structures beyond a certain
volume, because, among other things, diffusion of oxygen is
limited to around 250mm inside organs and tissues (Folkman,
1985). If this process fails, cell growth within the tissue ceases
and degenerates through an avascular necrotic process. The
capacity of tumours to induce neovascularisation was reported
over a century ago (Goldman, 1907), but it was not until the late
sixties of the twentieth century when it was proposed that tumour
cells secrete diffusible factors regulating vascular growth and
proliferation (Greenblatt and Shubi, 1968). The role of tumour
microenvironment is also an important matter to be considered for
our correct understanding of the vascular supply of neoplasias
(Nyberg et al, 2008).
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A total of 45 (12 control and 33 experimental) eight-week-old mice of
the 129 P2 Ola/Hsd (Harlan Laboratories, Barcelona, Spain) strain
were used. They were bred under a 12-h light–darkness cycle and
had free access to water and food.
Cell line
Transplanted ES cells belong to the AB1 cell line (McMahon and
Bradley, 1990) that has the same genetic background of the
recipient animals. For fluorescent labelling, cells were transfected
with the pEGFP plasmid (Clontech, Saint-Germain-en-Laye,
France; Cat. 6076-1) using the cationic lipid Lipofectamine 2000
(Invitrogen, Carlsbad, CA, USA; Cat. 11668-027). A fluorescent cell
colony was selected from the resulting culture and expanded in the
presence of the selection antibiotic G418.
Cellular transplantation
Cell transplants into the seminiferous tubules were carried out
following the Ogawa et al method (Ogawa et al, 1997) (Figure 1A).
Briefly, an AB1
GFP cell suspension (2 10
6cellsml
 1), containing
the visual tracer bromophenol blue at a non-toxic concentration,
was microinjected using sharpened borosilicate capillaries into
seminiferous tubules of Avertin-anaesthetised mice. The injection
pressure was generated by an Eppendorf air injector and the
process was carried out under a MZ Apo stereomicroscope (Leica
Microsystems, Wetzlar, Germany) with coaxial illumination.
Transplantation was considered satisfactory if most of the surface
tubules were filled by the cell suspension and no dye was seen in
the stroma. A total of 35 testes were correctly transplanted, of
which 17 (49%) developed a tumour. Mice were killed 5 weeks after
transplantation. All the experiments were carried out in vivo after
approval from the University of the Basque Country Ethical
Committee and were compliant with the UKCCCR Guidelines for
the Welfare of Animals in Experimental Neoplasias (Workman
et al, 1998).
Corrosion casting
Mice were anaesthetised with pentobarbital (0.1ml, Narcoren,
Merial, Germany) and aorta was catheterised with an olive-tipped
needle. The whole vascular tree was washed out with physiological
buffered saline including heparin (Liquemin 5000 IE, Roche Farma
Espan ˜a, Madrid, Spain). Next, 10ml of 2.5% glutaraldehyde in
Ringer’s saline solution and, subsequently, 40ml of Mercox CL-2B
resin (Vilene Med Co., Tokyo Japan) diluted with 20% methyl-
methacrylate monomers (Merck Darmstadt, Germany) were per-
fused. Then, the entire animal was immersed for 1h in a 401Cw a t e r
bath to facilitate resin polymerisation. Normal size and tumoral
testes were removed and immersed in a 5% KOH solution to digest
all the tissues around the vessel casts. One week later the specimens
were dehydrated, mounted on conductive stubs and coated with gold
in an SCD 040 sputter-coater (BAL-TEC AG, Leica Microsystems).
The specimens were visualised under a Philips XL30 scanning
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Figure 1 (A) Cell microinjection into the seminiferous tubules. The blue dye used to monitor the precision of transplantation can be seen filling the
seminiferous tubule network. (B) Shortly after transplantation, fluorescent cells (arrow) could be found in the lumen of the seminiferous tubules in cryostat
sections. (C) At 36h after transplantation, some of the AB1
GFP cells were found integrated in the seminiferous epithelium (arrow). (D) These cells were
recognised with anti-GFP-specific antibodies (arrows). Bars represent 250mm in image A and 100mm in images B, C and 50mm in image D.
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selectron microscope (Philips, Eindhoven, The Netherlands), and
between 20 and 30 stereo pair images with a 61 tilt angle were
recorded per sample.
Morphometry and statistical analysis
In order to carry out the morphometric study of vascular corrosion
casts, we used 13 tumour and 11 normal testes. Pairs of stereo images
were analysed with the image analysis program, Kontron KS 300
(Carl Zeiss Vision, Eching, Germany), to calculate the parameters
associated with microvascular architecture, such as the intervascular
and interbranching distances and the vascular diameters. For details
of reconstruction and calculations see Malkusch et al (1995).
Statistical analyses and graphic displays were performed using
Sigmaplot and SPSS software (Chicago, IL, USA). Statistical
significance was evaluated using the Mann–Whitney and Student’s
t-tests.
Immunohistochemistry
Rat primary antibodies (Santa Cruz Biotechnology Inc, Santa Cruz,
CA, USA) against CD31 and VEGF-R2 diluted 1:100 in saline
buffer were used to detect endothelial cell markers. Cryostat
sections were incubated for 1h with blocking serum (5% fetal calf
serum in saline buffer) and, later, overnight with the primary
antibody at 41C. Histological sections were incubated for 1h with
secondary fluorescent antibody (goat anti-rat Texas Red labeled,
Santa Cruz Biotechnology Inc, diluted 1:400). Results were
observed and photographed using a confocal scanning microscope
Fluoview FV500 (Olympus, Tokyo, Japan).
RESULTS
Undifferentiated AB1
GFP ES cells microinjected into the specific
microenvironment of mouse seminiferous tubules (Figure 1A)
did not differentiate into germinal or Sertoli cells, but rather
into teratocarcinomas. Thus, this ES cell transplant into mouse
seminiferous tubules mimics the niche of pre-invasive germinal
neoplasias of the testis (CIS), its earliest invasion stages and
the histopathology of teratocarcinomas (Pierce, 1967; Damjanov
et al, 1983). The presence of fluorescent ES cells inside the
seminiferous tubules, and not in the testis stroma, was confirmed
after their histological study of the injected testes shortly
after transplantation (Figure 1B). Thus, 36 hours after transplant-
ation, transplanted labelled ES cells were found integrated
into the seminiferous epithelium (Figure 1C), as evidenced
by using green fluorescent protein (GFP)-specific antibodies
(Figure 1D).
A total of 5 weeks after transplantation, a teratocarcinoma was
formed in 49% of injected testes (N¼35) and the tumours showed
the characteristic structure of the spontaneous EC of the testis
(Figures 2A and B). With regard to tumour vascularisation,
confocal microscopy histochemistry of endothelial cells of tumour
capillary vessels exhibited CD31 and VEGF-R2 immunoreactivity
and, simultaneously, exhibited GFP fluorescence, showing their
origin from the transplanted fluorescent ES cells (Figures 2C
and D). These findings indicate that transplanted ES cells have the
capacity to differentiate into neoplastic capillaries.
Scanning electron microscopy of vascular corrosion casting
samples of tumours showed capillaries with irregular diameters,
chaotic hierarchy and several blind-endings similar to those found
AB
CD
Figure 2 Histology and histochemistry of experimental teratocarcinoma tumours. (A) Epidermoid and osteoid differentiation. (B) Undifferentiated
embryonal carcinoma cells. Capillary-like structures positive for endothelial cell markers CD31 (in C) and VEGF-R2 (in D) co-localize with labelled cells
(green fluorescence) derived from transplanted AB1
GFP ES cells. Bars represent 50mm.
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sin lymphatic vessels. Resin extravasations and vascular compres-
sions were also frequent. These characteristics are typical of an
immature vascularisation pattern and differ significantly from
those observed in normal testis histology (Figure 3). These
differences were quantified by measuring three morphometric
parameters: (a) intervascular distance, (b) interbranching distance
and (c) vascular diameter.
The mean values and the standard deviation of the measured
parameters in both normal testis and experimental teratocarcino-
ma are represented in Figure 4. Maximal and minimal values are
shown in Table 1, together with the number of measurements and
the mean values.
As shown in Figure 4A, the mean intervascular distance was 15%
shorter in teratocarcinomas than in healthy testis and this
difference was statistically significant. Moreover, we observed that
the highest and lowest values of the mean were found in the
tumour casts (Table 1), an indication of the disorganisation of
tumour vascular network. Neoplastic and normal tissue vasculari-
sation showed also differences in their interbranching distances
(Figure 4A) and these were both, larger and of wider range, in the
tumour casts in comparison with the healthy organ.
The characteristic branching angles of the ladder-like pattern of
testis vasculature were completely lost in the tumours (Figure 3)
and the mean vascular diameter of its vessels (Figure 4A) was
130% larger than in normal testis. These data, together with the
shorter intervascular distances, which are indicative of a higher
vascular density, show that the volume occupied by vessels was
much larger in tumours than in normal testis. Once again, the
widest and the narrowest capillaries correspond to the tumour
vasculature casts (Table 1). Figure 4B illustrates the standard error
of the mean (s.e.m.) of the diameter for each segment in the
healthy organ and tumour casts; normal testis was associated with
a s.e.m. value of 9.2%, whereas the s.e.m. for tumour vasculature
was 14.7%. It is likely that the greater irregularity in vascular
diameters is associated with chaotic blood flow within the
disorganized tumour tissue.
DISCUSSION
The incidence of testicular germ cell tumours (TGCTs) in young
males has risen during last decades (Cooper et al, 2008) and this
increase seems to be related to the environmental factors, although
no consensus has yet been reached regarding the precise aetiology
(McGlynn et al, 2005; Shah et al, 2007). In contrast, these tumours
are very uncommon among non-human mammals. In this regard,
Murine gene deletions, that promote an increase in the incidence
of testis teratomas in 30% of carriers, have been reported a long
time ago (Stevens, 1973), but most of these tumours are
differentiated (benign teratomas) and, for that reason, not
adequate as a model for studying human testis teratomas, which
are usually malignant. An important fact to be underlined in this
regard is the phenotypic similarities between ES cells and testis CIS
cells (Andrews et al, 2005; Almstrup et al, 2006). For this reason,
ES cell microinjection inside mouse seminiferous tubules repre-
sents a model with high potential utility, because it mimics, in
many ways, the pre-invasive state of TGCTs.
In order to identify structures derived from microinjected cells, we
labelled Murine ES cells with GFP to facilitate their tracking after
transplantation into the seminiferous tubules. We found that most
A B
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Figure 3 Testis vascular casts of the longitudinal capillaries (A), which run parallel to seminiferous tubules, and of the transverse capillaries (B) that
connect longitudinal capillaries every 100–200mm and surround the seminiferous tubules, exhibiting the appearance of a honeycomb. Vascular
teratocarcinoma network with resin extravasations (C) and blind endings (D) marked with arrows. Bars represent 100mm in A and B, 50mmi nC and
250mmi nD.
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so ft h en e o p l a s t i ct i s s u ec o m e sf r o mt h eA B 1
GFP cells, although
fluorescence intensity was found to be quite heterogeneous. Never-
theless, it should be noted that the intensity of GFP fluorescence
labelling could depend on oxygen tension (Takahashi et al, 2006),
indicating that the heterogeneity of fluorescence intensity may be due
to the variable oxygen concentration inside the tumour.
In this study, we focused on tumour vascularisation because of
its importance for neoplastic invasion and metastasis of germinal
tumours. In this regard, two specific mechanisms of tumour vessel
growth have been identified to date, namely angiogenesis and
vasculogenesis (Carmeliet and Jain, 2000; Velazquez, 2007). In our
experimental model, we found evidence for another possible
mechanism, that of the genesis of neoplastic capillaries from the
highly plastic transplanted ES cells. Thus, some of the endothelial
cells of the experimental teratocarcinoma were found to express
the endothelial cell markers CD31 or VEGF-R2 and simultaneously
exhibited green fluorescence, indicating their origin from the
transplanted AB1
GFP cells. This ability of cancer stem cells to give
rise to capillary endothelia has been reported for other tumours,
such as lymphoma (Streubel et al, 2004), myeloma (Rigolin et al,
2006) and neuroblastoma (Pezzolo et al, 2007). In our experi-
mental teratomas, some of the cells covering the lumen of the
blood vessels were not found to express the above mentioned
endothelial markers, but such a ‘vessel mosaic’ has already been
described in other tumours (di Tomaso et al, 2005).
Earlier corrosion casting works have shown that branching
angles and interbranching distances are specific and characteristic
for each tissue including tumours (Konerding et al, 1995, 1999). In
our case, the vascular branching and bifurcation capillary pattern
of the normal testis totally disappeared and the examined
specimens exhibited features similar to an immature vascular
network with heterogeneous vessel densities, frequent blind-























































































Figure 4 (A) Comparison of the means from the measured parameters in normal testis capillaries (in dark grey) and teratocarcinoma capillaries
(in light grey). Statistically significant differences are indicated (***Po0.05). (B) Spectra of vessel diameters in healthy testis and teratocarcinoma. The
percent deviations from the mean diameter of four or five distinct points were calculated for each vessel segment (300 vessel segments were measured).
Teratocarcinoma samples seem to be characterized by a larger dispersion of these values, indicating a more chaotic vascular bed, probably because of the
imbalance of vasculogenesis regulation. Variation of the mean vessel diameter is shown in the upper right corners, and illustrates the much greater dispersion
in vascular size in tumours, in comparison with normal tissues.
Table 1 Vascular parameters in healthy and tumoral testis (N: registered
vascular measurements)
Normal testis Teratocarcinoma
Intervascular distances N 1931 2242
Mean 68.35 53.15
s.e.m. 0.90 0.85
Higher value 284.19 324.8
Lower value 8.02 4.03
Interbranching distances N 569 870
Mean 83.10 100
s.e.m. 1.88 3.17
Higher value 339.6 984.5
Lower value 11.67 2.34
Vascular diameter N 1840 2576
Mean 17.36 40.85
s.e.m. 0.18 0.5
Higher value 71.44 272.5
Lower value 4.91 3.76
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s1988). In this regard, intervascular distances were considered to be
a parameter indicative of vascular density, similar to microvessel
density used in earlier bidimensional studies. Capillaries in
experimental teratocarcinomas were about 15% closer than in
the healthy tissue. This increase in vascular density is common to
most tumours, although there are some exceptions; pituitary
tumours, for example, show higher intercapillary distances than
the equivalent healthy tissue (Turner et al, 2000). In some
tumours, such as retinoblastoma or nephroblastoma, vascular
density is used as a criterion for prognosis (Abramson et al, 2003;
Ro ¨ssler et al, 2004) because of the higher risk of metastasis
and better access of the tumour cells to nutrients and oxygen.
Finally, it is important to point out that the mean vascular
diameter of teratocarcinoma is about 2.4 times wider than in the
normal testis. This broader distribution of the diameters and the
higher values of the irregularities observed in different vascular
segments may be because of altered blood flow and to the high
pressure of the tumour stroma. Both characteristics would also
cause a higher vascular permeability and therefore worse clinical
prognosis.
Recent advances in stem cell research, such as the possibility of
obtaining pluripotent stem cells from adult tissues (Takahashi and
Yamanaka, 2006) and their capacity to differentiate in vitro into
almost all kinds of tissues, have generated many therapeutic
expectations (Atala, 2007; Fish and Grupp, 2008). However, as this
work shows, the risk of generating a tumour after these transplants
is a real possibility, especially when employing cultured stem cells.
This suggests that stem cells in the adult mammals may be under
physiological or epigenetic controls in order to be organ-specific;
this may be a defense mechanism to avoid defective differentiation
and tumour formation.
Nowadays, treatment of germinal tumours has a high success
rate (Gerl et al, 1996; Bosl, 1999). However, early tumour detection
and identification of the causes underlying their increased
incidence among young men remain to be determined, as do the
cellular and molecular mechanisms of CIS to EC cell transforma-
tion. We have developed a tumour model that can facilitate the
study of the pre-invasive state of malignant teratomas, based on
the tumorigenic potential of cultured ES cells. Tumours arising
from the transplantation of AB1
GFP cells recapitulate the pheno-
typic and molecular features of spontaneous human teratocarci-
nomas, substantiates the potential utility of this assay for the
screening of novel therapeutic strategies, particularly involving the
inhibition of angiogenesis and metastasis.
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